40 results on '"Alonso-Montes, Cristina"'
Search Results
2. RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction
3. #1496 High levels of sclerostin promote bone resorption and changes and mineral metabolism
4. #571 Vitamin D receptor from VSMCs regulates vascular calcification during CKD: a potential role for miR-145a
5. Novel Biomarkers of Bone Metabolism
6. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows
7. Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients.
8. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease
9. Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145
10. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis
11. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities
12. Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure
13. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment
14. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes
15. Regeneration of mandibular defects using adipose tissue mesenchymal stromal cells in combination with human serum-derived scaffolds
16. Lamin A is involved in the development of vascular calcification induced by chronic kidney failure and phosphorus load
17. MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification
18. New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy
19. CKD MBD
20. FC 079HIGH SERUM PHOSPHATE, A NOVEL POTENTIAL RISK FACTOR FOR BONE FRAGILITY FRACTURES IN THE COSMOS STUDY
21. Impact of vascular calcification on bone health and mortality in kidney transplant patients
22. Effects of calcitriol and paricalcitol on renal fibrosis in CKD
23. Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
24. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification
25. Chronic Kidney Disease—Mineral and Bone Disorders: Pathogenesis and Management
26. P1394ASSOCIATION BETWEEN PARATHYROID HORMONE AND MORTALITY IN HAEMODIALYSIS: THE DIABETES MAKES THE DIFFERENCE
27. Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.
28. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.
29. Variants in cardiac GATA genes associated with bicuspid aortic valve
30. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease
31. Rare Genetic Variants in Gata Transcription Factors in Patients with Hypertrophic Cardiomyopathy
32. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
33. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease
34. Bicuspid aortic valve syndrome: A heterogeneous and still unknown condition
35. Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy
36. Mitochondrial Transcription Factor A (TFAM) Gene Variation and Risk of Late-Onset Alzheimer's Disease
37. Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease
38. Mitochondrial Transcription Factors TFA, TFB1 and TFB2: A Search for DNA Variants/Haplotypes and the Risk of Cardiac Hypertrophy
39. Prevalence and spectrum of mutations in the sarcomeric troponin T and I genes in a cohort of Spanish cardiac hypertrophy patients
40. CELLULAR AND MOLECULAR MECHANISMS INVOLVED IN VASCULAR CALCIFICATION: THE ROLE OF LAMIN A
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.